Breaking News Instant updates and real-time market news.

MTOR

Meritor

$16.28

0.59 (3.76%)

15:30
10/25/18
10/25
15:30
10/25/18
15:30

Sweep call buyer targets Meritor January upside

Sweep call buyer targets Meritor January upside. Shares $16.22 after a 31-leg sweep hit the tape as a buyer paid 77 to 85cents for just over 2K Jan 18 calls. Shares jumped a dime at the same time, to 16.31, but quickly retraced. Opens a new position on the Michigan-based commercial vehicle parts maker who's shares saw highs over $29 in early February, and set a year low yesterday.

  • 14

    Nov

  • 13

    Dec

MTOR Meritor
$16.28

0.59 (3.76%)

09/14/18
PIPR
09/14/18
NO CHANGE
Target $37
PIPR
Overweight
Meritor should be bought ahead of December analyst day, says Piper Jaffray
Piper Jaffray analyst Alexander Potter reiterates an Overweight rating on shares of Meritor after visiting the company's joint venture in China. The analyst believes China represents an underappreciated aspect of the Meritor thesis, with a medium-term incremental revenue opportunity "easily totaling" hundreds of millions of dollars. The analyst recommends owning the stock ahead of the analyst day in December. He keeps a $37 price target on the shares.
03/13/18
LBOW
03/13/18
NO CHANGE
Target $32
LBOW
Buy
Longbow says recent weakness in Meritor shares unwarranted
Longbow analyst Faheem Sabeiha believes recent weakness in Meritor shares, attributed to fears from material cost headwinds and concerns that North American Class 8 market is peaking in 2018, is unwarranted. Sabeiha, who sees this as a great entry point into Meritor given the strong Class 8 fundamentals and its longer-term opportunities from its electric vehicle exposure, reiterates a Buy rating and $32 price target on the stock.
03/13/18
PIPR
03/13/18
NO CHANGE
Target $35
PIPR
Overweight
Meritor recent pullback a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Alexander Potter attributes the recent pullback in shares of Meritor to tariff concerns and a peaking Class 8 truck market. He thinks these factors are just "noise" but admits the stock's volatility could persist in the coming weeks. Following recent investor meetings with management, the analyst calls Meritor one of the most under-appreciated growth stories in his coverage. Potter recommends buying the stock at current levels with an Overweight rating and $35 price target.
01/24/18
LBOW
01/24/18
UPGRADE
Target $32
LBOW
Buy
Meritor upgraded to Buy on higher Class 8 production at Longbow
As previously reported, Longbow upgraded Meritor to Buy from Neutral with a $32 price target. Analyst Faheem Sabeiha believes risk/rewards is favorable ahead of expected strong earnings growth and sees potential upside to FY18 guidance of $2.20-$2.40 based on its North America Class 8 production outlook.

TODAY'S FREE FLY STORIES

VYGR

Voyager Therapeutics

$21.87

-0.28 (-1.26%)

16:36
05/20/19
05/20
16:36
05/20/19
16:36
Hot Stocks
Voyager Therapeutics announces retirement of chief scientific officer Dinah Sah »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

OCUL

Ocular Therapeutix

$3.36

-0.1 (-2.89%)

16:35
05/20/19
05/20
16:35
05/20/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Ocular Therapeutix »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 10

    Nov

HI

Hillenbrand

$38.98

0.05 (0.13%)

16:34
05/20/19
05/20
16:34
05/20/19
16:34
Initiation
Hillenbrand initiated  »

Hillenbrand initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

VAR

Varian Medical

$130.48

-0.26 (-0.20%)

16:34
05/20/19
05/20
16:34
05/20/19
16:34
Earnings
Varian Medical cuts FY19 adj. EPS view to $4.55-$4.70 from $4.60-$4.75 »

Consensus $4.70. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 31

    May

MRK

Merck

$78.86

0.15 (0.19%)

16:34
05/20/19
05/20
16:34
05/20/19
16:34
Hot Stocks
Merck announces Phase 3 KEYNOTE-119 trial does not meet OS primary endpoint »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

  • 03

    Jun

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 20

    Sep

VAR

Varian Medical

$130.48

-0.26 (-0.20%)

16:33
05/20/19
05/20
16:33
05/20/19
16:33
Hot Stocks
Varian to acquire Cancer Treatment Services for $283M »

Varian Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 31

    May

NDSN

Nordson

$130.42

-4.8 (-3.55%)

16:33
05/20/19
05/20
16:33
05/20/19
16:33
Hot Stocks
Nordson CEO says 'continue to forecast organic growth' for 2019 »

CEO Michael Hilton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 13

    Jun

NDSN

Nordson

$130.42

-4.8 (-3.55%)

16:32
05/20/19
05/20
16:32
05/20/19
16:32
Hot Stocks
Breaking Hot Stocks news story on Nordson »

Nordson reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 13

    Jun

REGN

Regeneron

$302.51

-2.3 (-0.75%)

, NVS

Novartis

$82.02

-0.7 (-0.85%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31
Initiation
Regeneron, Novartis, Sanofi initiated at Credit Suisse »

Regeneron initiated with…

REGN

Regeneron

$302.51

-2.3 (-0.75%)

NVS

Novartis

$82.02

-0.7 (-0.85%)

SNY

Sanofi

$41.40

-0.53 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 23

    May

  • 31

    May

  • 14

    Jun

  • 26

    Jun

TMO

Thermo Fisher

$263.13

1.44 (0.55%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31
Hot Stocks
Thermo Fisher to invest $50M to expand bioproduction capabilities »

Thermo Fisher announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 31

    May

  • 02

    Dec

NDSN

Nordson

$130.42

-4.8 (-3.55%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31
Earnings
Nordson reports Q2 adjusted EPS $1.54, consensus $1.60 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 13

    Jun

NBIX

Neurocrine

$76.64

-2.39 (-3.02%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31
Initiation
Neurocrine initiated  »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CNS

Cohen & Steers

$50.01

-0.275 (-0.55%)

, TROW

T. Rowe Price

$104.18

-0.24 (-0.23%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31
Hot Stocks
Cohen & Steers names Paul Zettl chief marketing officer »

Paul Zettl has joined…

CNS

Cohen & Steers

$50.01

-0.275 (-0.55%)

TROW

T. Rowe Price

$104.18

-0.24 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

16:30
05/20/19
05/20
16:30
05/20/19
16:30
Options
Preliminary option volume of 17.5M today »

Preliminary option volume…

VRTX

Vertex

$165.71

-2.97 (-1.76%)

16:29
05/20/19
05/20
16:29
05/20/19
16:29
Initiation
Vertex initiated at Credit Suisse »

Vertex initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ASNA

Ascena Retail

$1.13

-0.125 (-9.96%)

16:28
05/20/19
05/20
16:28
05/20/19
16:28
Hot Stocks
Ascena Retail announces wind down of Dressbarn »

Ascena Retail announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$65.85

-0.49 (-0.74%)

16:26
05/20/19
05/20
16:26
05/20/19
16:26
Initiation
Gilead initiated at Credit Suisse »

Gilead initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BIIB

Biogen

$230.70

1.49 (0.65%)

16:24
05/20/19
05/20
16:24
05/20/19
16:24
Initiation
Biogen initiated at Credit Suisse »

Biogen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SWI

SolarWinds

$19.16

0.04 (0.21%)

16:23
05/20/19
05/20
16:23
05/20/19
16:23
Syndicate
SolarWinds files to sell 17.25M shares of common stock »

JPMorgan, Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

AMGN

Amgen

$168.36

-1.5 (-0.88%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Initiation
Amgen initiated at Credit Suisse »

Amgen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

GM

General Motors

$36.98

-0.02 (-0.05%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Periodicals
GM plans wind-down of Maven car-sharing service in some cities, WSJ says »

According to the Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 01

    Aug

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

, AIMT

Aimmune

$19.68

-0.41 (-2.04%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Initiation
DBV Technologies, Aimmune initiated  »

Aimmune assumed with an…

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

AIMT

Aimmune

$19.68

-0.41 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVNA

Carvana

$67.17

-0.935 (-1.37%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Syndicate
Carvana files to sell 3.5M shares of Class A common stock »

Wells Fargo Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

INCY

Incyte

$76.83

-0.41 (-0.53%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Initiation
Incyte initiated at Credit Suisse »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 24

    May

  • 31

    May

  • 05

    Jun

  • 13

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.